Several damage biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18) have been studied in AKI, however these biomarkers tended to be specific with some clinical setting and gave some limitations. The gene discussed is LCN2; the disease is acute kidney injury.